新維國際控股(08086.HK)擬於中國互聯網醫療市場尋求商機
格隆匯8月31日丨新維國際控股(08086.HK)宣佈,公司擬於中國互聯網醫療市場尋求商機。
董事會認為,互聯網及移動技術所帶來的聯通性已經對中國人民醫療管理方面帶來了重大轉變。監於COVID-19疫情持續爆發,中國人民更為頻繁通過視頻會議或移動技術尋求醫療諮詢。此外,中國政府一直非常重視利用互聯網及移動技術提高醫療行業的運營效率,以有效解決看病難、看病貴的問題。近年來,中國政府亦頒佈多項政策以推動醫療行業數字化。
為於中國互聯網醫療市場及其他相關領域尋求商機,公司之間接全資附屬公司深圳市新維醫療投資控股有限公司("新維醫療投資")於中國註冊成立。預計新維醫療投資將成為公司於中國互聯網醫療市場及其他相關領域的投資工具,且公司已與中國互聯網醫療行業的其他市場參與者進行商討,以期尋求與彼等的業務合作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.